人类超可塑性前列腺的收缩反应的上腺肌肉协同作用
Ben T Blake-James1, Basu Chakrabarty2, Christopher H Fry2
1Division of Surgery & Interventional Science, University College London, London, UK.
International neurourology journal
|March 10, 2024
概括
上腺肌肉蛋白协同作用,一种超额外的收缩反应,存在于人类的前列腺组织中. 这一发现表明,阿尔法阻断剂和抗肌肉类药物的联合治疗可能有助于缓解良性前列腺增生症的症状.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 生理学 生理学 生理学
背景情况:
- 下泌尿道表现出上腺-肌肉激素协同作用,这是对同时使用α-上腺受体和肌肉激素受体激素剂的超额外收缩反应.
- 这种协同作用是具有双交感和副交感内置的区域的特征.
研究的目的:
- 为了调查前列腺组织中的上腺-肌肉蛋白协同作用的存在,从男性与良性前列腺扩大.
- 为了测试这种协同反应发生在前列腺组织中的假设.
主要方法:
- 从经过尿道切除前列腺切除的患者获得了隔离的前列腺组织条纹.
- 在体外以36°C的温度进行同度张力测量,以评估收缩反应.
主要成果:
- 烯和卡巴胆,分别应用,诱导了收缩,而烯显示出更大的最大反应.
- 在卡巴霍尔的存在下,烯的强度和最大反应显著增加,显示出协同效应.
- 协同反应是由肌肉蛋白受体对抗剂调节的,主要是M3和M2亚型,表明它们参与了调解.
结论:
- 上腺和肌肉的收缩协同作用是人类前列腺组织的特征.
- 这种协同作用具有潜在的治疗意义,建议对良性前列腺增生症症状进行阿尔法阻断剂和抗肌糖类药物的联合治疗.
- 组合疗法可能适合那些可以耐受抗类药物的患者,而不存在尿的风险.
更多相关视频
相关概念视频
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Cholinergic Receptors: Muscarinic
2.2K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.2K
Adrenergic Receptors (Adrenoceptors): Classification
2.5K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.5K
Cholinergic Antagonists: Pharmacological Actions
1.1K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.1K


